Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Sudair Pharma aims to localise insulin production, contributing to the continuity of supply and reducing reliance on imports ...
24/7 Wall St. on MSN12h
AbbVie Just Paid Investors: Here's How Much They ReceivedAbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...
As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...
Led by Life Sciences and Advanced Manufacturing, $15B in New Investment Demonstrates North Carolina’s Economic Strength North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback